- Home
- WRAP vs ACOG Comparison
WRAP vs ACOG Comparison
Compare WRAP & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- ACOG
- Stock Information
- Founded
- WRAP 2016
- ACOG 2000
- Country
- WRAP United States
- ACOG Canada
- Employees
- WRAP N/A
- ACOG N/A
- Industry
- WRAP Ordnance And Accessories
- ACOG
- Sector
- WRAP Industrials
- ACOG
- Exchange
- WRAP Nasdaq
- ACOG Nasdaq
- Market Cap
- WRAP 73.3M
- ACOG 80.3M
- IPO Year
- WRAP N/A
- ACOG N/A
- Fundamental
- Price
- WRAP $1.49
- ACOG $10.80
- Analyst Decision
- WRAP
- ACOG Strong Buy
- Analyst Count
- WRAP 0
- ACOG 1
- Target Price
- WRAP N/A
- ACOG $20.00
- AVG Volume (30 Days)
- WRAP 154.8K
- ACOG 67.2K
- Earning Date
- WRAP 05-15-2025
- ACOG 08-14-2025
- Dividend Yield
- WRAP N/A
- ACOG N/A
- EPS Growth
- WRAP N/A
- ACOG N/A
- EPS
- WRAP N/A
- ACOG N/A
- Revenue
- WRAP $3,796,000.00
- ACOG $2,928,654.00
- Revenue This Year
- WRAP N/A
- ACOG N/A
- Revenue Next Year
- WRAP N/A
- ACOG N/A
- P/E Ratio
- WRAP N/A
- ACOG N/A
- Revenue Growth
- WRAP N/A
- ACOG N/A
- 52 Week Low
- WRAP $1.30
- ACOG $3.75
- 52 Week High
- WRAP $2.58
- ACOG $11.54
- Technical
- Relative Strength Index (RSI)
- WRAP 45.97
- ACOG N/A
- Support Level
- WRAP $1.51
- ACOG N/A
- Resistance Level
- WRAP $1.60
- ACOG N/A
- Average True Range (ATR)
- WRAP 0.08
- ACOG 0.00
- MACD
- WRAP -0.01
- ACOG 0.00
- Stochastic Oscillator
- WRAP 28.57
- ACOG 0.00
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.